?Who binds to it. ? Who binds these inflammatory proteins RAGE SUGAR-FREE GLYCOBIOLOGY INFLAMMATION. BASIC SCIENCE?sugar chain structure

Similar documents
Faecalibacterium prausnitzii

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine

Review Questions: Janeway s Immunobiology 8th Edition by Kenneth Murphy

Supplementary Figure 1. Characterization of basophils after reconstitution of SCID mice

Genetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD

17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012

Chapter 3, Part A (Pages 37-45): Leukocyte Migration into Tissues

Date of preparation: 06/ IBD/

LECTURE 12: MUCOSAL IMMUNITY GUT STRUCTURE

Mucosal Immunology Sophomore Dental and Optometry Microbiology Section I: Immunology. Robin Lorenz

A crucial role for HVEM and BTLA in preventing intestinal inflammation

Putting it Together. Stephen Canfield Secondary Lymphoid System. Tonsil Anterior Cervical LN s

The Case of the Spring Break Consequences

Nutrition & Gut Immunity

Supplementary Material

T cell maturation. T-cell Maturation. What allows T cell maturation?

Innate immunity as a therapeutic target in IBD. Elke Cario Division of Gastroenterology & Hepatology University Hospital of Essen Essen, Germany

Escherichia coli Nissle 1917

TCR, MHC and coreceptors

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

12/10/2009. Department of Pathology, Case Western Reserve University. Mucosal Cytokine Network in IBD

Differential responses of human colonic ILCs to gut commensal bacteria altered during HIV infection

Lecture 11: Mucosal Immunity (based on lecture by Dr. Betsy Herold, Einstein)

ONLINE SUPPLEMENT MATERIAL. CD70 limits atherosclerosis and promotes macrophage function.

SUPPLEMENTARY INFORMATION

Innate immune cells---- one time migration preprogrammed homing properties

Innate Immunity II. Integration. Lindsay Nicholson Advanced Immunology L2

Supplementary Figure 1. mrna expression of chitinase and chitinase-like protein in splenic immune cells. Each splenic immune cell population was

Immune response to infection

SUPPLEMENTARY INFORMATION

The Immune Response in Time and Space

FOR OPTIMAL GUT HEALTH KEMIN.COM/GUTHEALTH

IL-12 family members in experimental colitis. Markus F. Neurath I. Medical Clinic Johannes Gutenberg-University Mainz, Germany

Gp96-Ig-SIV VACCINES INDUCE PREDOMINANT IMMUNE RESPONSES AT MUCOSAL SITES

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier

Dendritic cells in cancer immunotherapy Aimin Jiang

Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides

Adaptive immune responses: T cell-mediated immunity

Animal Models to Understand Immunity

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells

Accepted Manuscript. Innate immune cells regulate oncoimmunity and cancer development. Ai-Ping Bai, Yuan Guo

Immunology, Faculty of Medicine University of Bari, Bari (Italy) Proprietà benefiche di latte, vino e olio extra vergine di oliva

B cell activation and antibody production. Abul K. Abbas UCSF

New and Future Adhesion Molecule Based Therapies in IBD

SUPPLEMENTARY MATERIAL

Immunology MIMM-314 MID-TERM II EXAMINATION. 1 hour between 8:30 a.m. - 10:00 a.m. McIntyre Medical Rm 504 (Martin Amphitheatre)

A Novel Class of Living Medicines

Selective leucocyte trafficking inhibitors for treatment of IBD

T Cell Activation. Patricia Fitzgerald-Bocarsly March 18, 2009

Probiotic bacteria: mechanisms of action?

T Regulatory Cell and Body Tolerance

ASH 2011 aktualijos: MSC TPŠL gydyme. Mindaugas Stoškus VULSK HOTC MRMS

IL-24 AND ITS ROLE IN WOUND HEALING

SUBDIVISIONS OF THE MUCOSA Distinct features of type I and type II mucosal surfaces

Monocytes must also leave the circulation in response to inflammatory signals, and neutrophils and other granulocytes must be able to do so as well.

CD40L TCR IL-12 TLR-L

SUPPLEMENTARY INFORMATION

Supplementary Figure 1 IL-27 IL

ROMANIAN ACADEMY INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU. PhD THESIS Summary

Cytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins,

T Lymphocyte Activation and Costimulation. FOCiS. Lecture outline

Sharon S. Evans, Ph.D. Dept. Immunology, RPCI Jan. 29 & Feb 3, 2015

Basis of Immunology and

Supplementary information CD4 T cells are required for both development and maintenance of disease in a new model of reversible colitis

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital

Follicular Lymphoma. ced3 APOPTOSIS. *In the nematode Caenorhabditis elegans 131 of the organism's 1031 cells die during development.

Muramyl dipeptide activation of nucleotidebinding oligomerization domain 2 protects mice from experimental colitis

Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis

Parallel session IVB. Chair: Hans Wildiers

The T cell receptor for MHC-associated peptide antigens

Asthma. In Europe ~30 million children and adults under 45 have asthma. On average 3 people a day die from asthma in the UK

BUT ONLY MINIMALLY AFFECTS OTHER INDICATORS OF COLONIC INTEGRITY IN A RAT MODEL OF

New treatment options in IBD: today and the future. Silvio Danese Istituto Clinico Humanitas, Milan, Italy

Presented by Lucas Nemec. Nat. Med. 21, (2015)

Adaptive Immunity. Jeffrey K. Actor, Ph.D. MSB 2.214,

Supplementary Information

Immune Checkpoints. PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich

INFLAMMATORY BOWEL DISEASE (IBD)

Tolerance 2. Regulatory T cells; why tolerance fails. Abul K. Abbas UCSF. FOCiS

CHAPTER 9 BIOLOGY OF THE T LYMPHOCYTE

Supplemental Table 1. Primers used for RT-PCR analysis of inflammatory cytokines Gene Primer Sequence

Supplementary Figure 1. H-PGDS deficiency does not affect GI tract functions and anaphylactic reaction. (a) Representative pictures of H&E-stained

Intestinal Microbiota in Health and Disease

Effector T Cells and

The mouse cholera toxin model for evaluation of allergenicity

Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease

Nonspecific External Barriers skin, mucous membranes

T Cell Effector Mechanisms I: B cell Help & DTH

ROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret

B and T cell Memory. Bengt Lindbom Adap6ve Immunity BMC D14

TD-BF01: Innate immunity to microorganisms

Robert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School

Therapies for IBD: the Pipeline. New Therapeutic Agents in IBD

for six pairs of mice. (b) Representative FACS analysis of absolute number of T cells (CD4 + and

Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel

News dalla ricerca: identificazione di nuove molecole come target di terapia nelle infiammazioni intestinali

Oncologist-induced Disease of the GI tract: New Developments

Transcription:

SUGAR-FREE GLYCOBIOLOGY BASIC SCIENCE?sugar chain structure Unusual Sugar Chain It -- is a carboxylate Make lots of It Make an It antibody Inflammatory proteins?who binds to it? Who binds these inflammatory proteins RAGE INFLAMMATION

Expansion, homing and activation of CD4CD45RB hi naive T cells CD4CD45RB hi (naïve) Mesenteric lymph nodes Priming and clonal expansion Involves interaction with DCs IL12 CD8/86-CD28 CD4-CD154 CD134L-CD134 Acquire gut homing molecules α4β7, CCR9 Recognized by addressin molecules on vascular endothelium of intestine and home to lamina propria Th1 Lamina Propria CD4-CD154 CD8/86-CD28 CD134L-CD134 leukocyte recruitment from blood and Inflammation Proinflammatory Cytokines TNFα IFNγ IL-12, IL-23 NO MIF macrophages Apoptotic pathways

Expansion, homing and activation of CD4CD45RB hi naive T cells CD4CD45RB hi (naïve) Mesenteric lymph nodes Priming and clonal expansion Involves interaction with DCs IL12 CD8/86-CD28 CD4-CD154 CD134L-CD134 Acquire gut homing molecules α4β7, CCR9 Recognized by addressin molecules on vascular endothelium of intestine and home to lamina propria Th1 Lamina Propria CD4-CD154 CD8/86-CD28 CD134L-CD134 leukocyte recruitment from blood and Inflammation Proinflammatory Cytokines TNFα IFNγ IL-12, IL-23 NO MIF macrophages Apoptotic pathways

IL-1 pg/ml 16 12 IL-12 p4 Secretion of cytokines from LPS-activated RAW264.7 murine macrophages 8 4 TNFα ng/1 6 cells IL12p4 pg/ml 16 12 TNFα 8 4 2 16 12 8 4 IL-1 untreated LPS LPS+GB3.1 LPS+control Ab

mabgb3.1 inhibits LPS-induced TNFα and IL23p19 gene expression in murine macrophages.7.6.5.4.3.2.1 TNF α untreated LPS treated LPS + GB3.1 LPS + control Ab.6.5 IL-23p19.4.3.2.1. [-LPS] [+LPS] [+LPS/GB3] [+LPS/cAb]

% of total cells in unactivated cultures 12 1 8 6 4 2 GB3.1 augments cell death of activated macrophages 2 4 6 8 Time after LPS activation (h) -LPS LPS Activated macrophages +LPS +LPS/cAb +LPS/+GB3.1 12 % of total cells in untreated cultures 1 8 6 4 2 Unactivated macrophages 2 4 6 8 Time of treatment (h)

mabgb3.1 inhibits onset of colitis GB3.1 reduces CD4+ T cell accumulation specifically in colon tissues GB3.1 does not induce significant apoptosis of unactivated or activated T-cells GB3.1 inhibited recruitment of monocytes into inflammed areas or caused apoptosis of recruited macrophages No upregulation of MAdCAM expression Proinflammatory cytokine production is reduced Signaling pathways involved?

p65 [LPS activation] p65 [IFN/LPS] NF-kappaB p65.28.24.2.16.12.8.4 [unactivated] [activated] [activated/gb3.1] [activated/cab]

NF-kappaB p65 is enhanced in colon of Crohn s patients Did GB3.1 block NF-κB in treated mice cells? 1.4 NF-kB levels in colonic lamina propria cells cab Tx 1.2 1.8.6 GB3 Tx Normal p65 RelB.4.2 1 2 3 4 5 6 mouse #

WILL GB3.1 REVERSE COLITIS? early Day 9 Day21 Leithhauser et al Lab Invest 81, 1339, 21

Clinical Symptoms Reconstituted, Untreated/cAb treated Loss of weight, loss of hair, soft stools, ill Reconstituted, GB3.1 treated Minimal weight loss, no hair loss, normal stools, healthy

Weight loss curves 12 11 1 AJ944 (control B) AJ3524 (Control A) AJ2527 (GB3.1) 9 8 7 1 2 3 4 5 Days post transfer

mabgb3.1 treatment reverses colitis in the emerging phase of disease inflammation: proximal colon 7 6 5 4 3 2 1 no cell transfer cell transfer/untreated cell transfer/cab treated Treatment cell transfer/gb3.1 treated

mabgb3.1 treatment reverses colitis in the emerging phase of disease inflammation: distal colon 8 7 6 5 4 3 2 1 no cell transfer cell transfer/untreated cell transfer/cab treated Treatment cell transfer/gb3.1 treated

mabgb3.1 treatment reverses colitis in the emerging phase of disease No cell transfer Reconstituted/ untreated Reconstituted/ cab Treated Reconstituted/ mabgb3.1 treated

CONCLUSIONS ANTICARBOXYLATE ANTIBODY GB3.1 BLOCKS THE ONSET OF COLITIS THE ANTIBODY ALSO SEEMS TO REVERSES ESTABLISHED COLITIS EFFECTS ARE PROBABLY MEDIATED BY APOPTOSIS OF ACTIVATED MACROPHAGE GB3.1 MAY BE A POTENTIAL TREATMENT FOR IBD In this collaboration between the Freeze and Kronenberg labs Geetha Srikrishna pioneered these studies and contributed most of the data